Healthcare

Request for TOC Request for Sample
BUY NOW

Europe Electrophysiology Market - Industry Trends and Forecast to 2029

Healthcare | Upcoming Report | Dec 2021 | Europe | 175 Pages | No of Tables: 220 | No of Figures: 60

Report Description

Europe Electrophysiology Market, By Product (Ablation Catheters, Laboratory Devices, Diagnostic Catheters, Access Devices, Other Products), Target Disease (Atrial Fibrillation, Atrial Flutter, Wolff-Parkinson-White, Syndrome, Atrioventricular Nodal Reentry, Tachycardia, Others), End User (Hospitals, ASCs), Country (Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe)-Industry Trends and Forecast to 2029.

Get Exclusive Sample Copy of this Report Here

Market Analysis and Insights : Europe Electrophysiology Market

The electrophysiology market is expected to witness market growth at a rate of 7.5% in the forecast period of 2022 to 2029. Data Bridge Market Research report on aviation analytics market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in the demand for ablation catheter process is escalating the growth of electrophysiology market.

Electrophysiology refers to a biomedical field that basically studies electric activities inside body which helps to detect diseases or disorder in body in early stage. Moreover, the various type of diseases targeted within this are as atrial fibrillation, atrioventricular nodal reentry, Wolff-Parkinson-white, atrial flutter, syndrome, tachycardia, and others.

Major factors that are expected to boost the growth of the electrophysiology market in the forecast period are the Increasing cases of heart failures and other target disease. Furthermore, the advancement in technology in field of electrophysiology is further anticipated to propel the growth of the electrophysiology market. On the other hand, the lack of skilled professionals and strict regulation policies is further projected to impede the growth of the electrophysiology market in the timeline period.

In addition, the development and innovation of new technologies such as ablation catheters with cost effectiveness with rising demand for early detection of disorder will further provide potential opportunities for the growth of the electrophysiology market in the coming years. However, the high installation cost and lack of awareness might further challenge the growth of the electrophysiology market in the near future.

This electrophysiology market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Data Bridge Market Research electrophysiology market contact us for an Analyst Brief, our team will help you take an informed market decision to achieve market hgrowth.

Europe Electropysiology Market Scope and Market Size

Electrophysiology market is segmented on the basis of product, end user and target diseases. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • On the basis of product, the electrophysiology market is segmented into ablation catheters, laboratory devices, diagnostic catheters, access devices, and other products. Abalation catheter is further segmented into cryoablation EP catheters, radiofrequency ablation catheters, microwave ablation systems, laser ablation systems and others. Laboratory devices is sub segmented into EP X-ray systems, 3D mapping system, EP recording systems, EP remote steering systems, and others. Diagnostic catheters is further segmented into conventional EP diagnostic catheters, advanced EP diagnostic catheters, and ultrasound EP diagnostic catheters.
  • On the basis of target disease, the electrophysiology market is segmented into atrial fibrillation, atrial flutter, Wolff-Parkinson-white, syndrome, atrioventricular nodal reentry, tachycardia, and others.

Electrophysiology Market Country Level Analysis

Electrophysiology market is segmented on the basis of product, end user and target diseases.

The countries covered in the electrophysiology market report are Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, and Rest of Europe in Europe.

U.K. and Germany dominate the electrophysiology market due to the development in technology and the growing investment in healthcare sector from government to enhance healthcare infrastructure. Furthermore, the rise in the geriatric population and growing diseases with complications will further boost the growth of the electrophysiology market in the region during the forecast period.

The country section of the electrophysiology market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

Electrophysiology market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for electrophysiology market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the electrophysiology market. The data is available for historic period 2010 to 2020.

Competitive Landscape and Electrophysiology Market Share Analysis

Electrophysiology market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, North America presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to electrophysiology market.

Some of the major players covered in the electrophysiology market report are Boston Scientific Corporation, GENERAL ELECTRIC COMPANY, Abbott, Biosense Webster, Inc., Microsoft, BIOTRONIK, Koninklijke Philips N.V., Medtronic, Inc., Seimens, Pioneer Medical Devices AG, and TZ Medical, Inc., among others.


SKU-

Table of Content

1. INTRODUCTION

      1.1. OVERVIEW OF THE EUROPE ELECTROPHYSIOLOGY MARKET
      1.2. MARKET SEGMENTATION & COVERAGE
                     1.2.1. CURRENCY AND PRICING 
                     1.2.2. LIMITATION
                     1.2.3. STAKEHOLDERS

2. RESEARCH METHODOLOGY

      2.1. KEY TAKEAWAYS
      2.2. ARRIVING AT THE EUROPE ELECTROPHYSIOLOGY MARKET SIZE
                     2.2.1. MARKET CRACKDOWN APPROACH 
                     2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS
                     2.2.3. DATA TRIANGULATION
                     2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES
                     2.2.5. PRODUCT PIPELINE ANALYSIS
                     2.2.6. PORTER’S FIVE FORCES MATRIX

3. MARKET LANDSCAPE SUMMARY

4. PREMIUM INSIGHTS

       4.1. OVERVIEW
       4.2. EUROPE ELECTROPHYSIOLOGY MARKET: KEY PRIMARY INSIGHTS
       4.3. MARKET OVERVIEW
                       4.3.1. DRIVERS
                                     4.3.1.1. RISING PREVALENCE OF CHRONIC DISEASE SUCH AS CARDIOVASCULAR DISEASES
                                     4.3.1.2. INCREASED PATIENT AWARENESS ABOUT DISGNOSIS AND TREATMENT
                                     4.3.1.3. AGEING EUROPE POPULATION
                                     4.3.1.4. NUMBER OF CARDIAC DEVICE IMPLANTATIONS
                       4.3.2. RESTRAINTS
                       4.3.3. OPPURTUNITIES
                       4.3.4. THREATS
       4.4. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES

5. EXECUTIVE SUMMARY

6. EUROPE ELECTROPHYSIOLOGY MARKET, BY TYPE

       6.1. OVERVIEW
       6.2. EUROPE ELECTROPHYSIOLOGY, BY TYPE
                       6.2.1. ELECTROPHYSIOLOGY MONITORING DEVICES
                                     6.2.1.1. ELECTROCARDIOLOGY
                                     6.2.1.2. HOLTER MONITORING DEVICES
                                     6.2.1.3. EVENT MONITORS
                                     6.2.1.4. DIAGNOSTIC CATHETERS
                                     6.2.1.5. X-RAY SYSTEMS
                       6.2.2. ELECTROPHYSIOLOGY TREATMENT DEVICES
                                     6.2.2.1. ABLATION CATHETERS
                                     6.2.1.2. PACE MAKERS
                                     6.2.1.3. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
                                     6.2.1.4. CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS (CRT-D)
                                     6.2.1.5. CARDIAC RESYNCHRONIZATION THERAPY PACEMAKERS (CRT-P)
                                     6.2.1.4. IMPLANTABLE LOOP RECORDERS

7. EUROPE ELECTROPHYSIOLOGY MARKET, BY PRODUCT TYPE

       7.1. OVERVIEW
       7.2. EUROPE ELECTROPHYSIOLOGY, BY PRODUCT TYPE
                       7.2.1. ELECTROPHYSIOLOGY ABLATION CATHETERS
                                     7.2.1.1. RADIOFREQUENCY
                                     7.2.1.2. CRYOBLATION
                                     7.2.1.3. LASER ABLATION
                                     7.2.1.4. NAVIGATIONAL ADVANCED MAPPING ACCESSORIES
                                     7.2.1.5. MICROWAVE
                       7.2.2. ELECTROPHYSIOLOGY DIAGNOSTIC CATHETERS
                                     7.2.2.1. CONVENTIONAL EP DIAGNOSTIC CATETERS
                                     7.2.1.2. ADVANCED EP DIAGNOSTIC
                                     7.2.1.3. ULTRASOUND EP DIAGNOSTIC
                       7.2.3. ELECTROPHYSIOLOGY LABORATORY DEVICES
                                     7.2.1.1. X-RAY SYSTEMS
                                     7.2.1.2. 3-D MAPPING SYSTEMS
                                     7.2.1.3. REMOTE STEERING SYSTEMS
                                     7.2.1.4. INTRA CARDIAC ECHOCARDIOGRAPHIC SYSTEMS(ICE)
                                     7.2.1.5. RADIO FREQUENCY (RF) ABLATION GENERATORS
                                     7.2.1.6. EP RECORDING SYSTEMS                 
                           7.2.4. ACCESS DEVICES          

8. EUROPE ELECTROPHYSIOLOGY MARKET, BY INDICATION

       8.1. OVERVIEW
       8.2. EUROPE ELECTROPHYSIOLOGY, BY INDICATION
                       8.2.1. ATRIAL FIBRILLATION
                       8.2.2. ATRIAL FLUTTER
                       8.2.3.  VENTRICULAR FIBRILLATION
                       8.2.4. VENTRICULAR TACHYCARDIA
                       8.2.1. ATRIAL TACHYCARDIA
                       8.2.2. WOLFF- PARKINSON- WHITE SYNDROME(WPW)
                       8.2.3. ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA

9. EUROPE ELECTROPHYSIOLOGY MARKET, BY GEOGRAPHY

       9.1. COUNTRYWISE EUROPE ELECTROPHYSIOLOGY MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
                       9.1.1. EUROPE
                                     9.1.2.1. GERMANY
                                     9.1.2.2. FRANCE
                                     9.1.2.3. U.K.
                                     9.1.2.4. ITALY
                                     9.1.2.5. SPAIN
                                     9.1.2.6. RUSSIA
                                     9.1.2.7. TURKEY
                                     9.1.2.8. BELGIUM
                                     9.1.2.9. NETHERLANDS
                                     9.1.2.10. SWITZERLAND
                                     9.1.2.11. REST OF EUROPE
       9.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

10. EUROPE ELECTROPHYSIOLOGY MARKET: COMPETITIVE LANDSCAPE

       10.1. EUROPE ELECTROPHYSIOLOGY MARKET : COMPANY SHARE ANALYSIS
       10.2. GERMANY ELECTROPHYSIOLOGY MARKET MARKET: COMPANY SHARE ANALYSIS
       10.3. FRANCE  ELECTROPHYSIOLOGY MARKET MARKET: COMPANY SHARE ANALYSIS
       10.4. U.K.  ELECTROPHYSIOLOGY MARKET: COMPANY SHARE ANALYSIS
       10.5. MERGERS & ACQUISITIONS
       10.6. NEW PRODUCT DEVELOPMENT & APPROVALS
       10.7. EXPANSIONS
       10.8. REGULATORY CHANGES
       10.9. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

11. GERMANY ELECTROPHYSIOLOGY MARKET: COMPANY SHARE ANALYSIS, COMPANY PROFILES

         11.1. ABOTT LABORATORIES
                            11.1.1. COMPANY OVERVIEW
                            11.1.2. REVENUE ANALYSIS
                            11.1.3. PRODUCT PORTFOLIO
                            11.1.4. RECENT DEVELOPEMENTS
                            11.1.5. DATA BRIDGE ANALYSIS
         11.2. BIOTRONIK SE & CO. KG
                            11.2.1.  COMPANY OVERVIEW
                            11.2.2. REVENUE ANALYSIS
                            11.2.3. PRODUCT PORTFOLIO
                            11.2.4. RECENT DEVELOPEMENTS
                            11.2.5. DATA BRIDGE ANALYSIS
         11.3. BOSTON SCIENTIFIC
                            11.3.1. COMPANY OVERVIEW
                           11.3.2. REVENUE ANALYSIS
                           11.3.3. PRODUCT PORTFOLIO
                           11.3.4. RECENT DEVELOPEMENTS
                           11.3.5. DATA BRIDGE ANALYSIS
         11.4. GE HEALTHCARE
                             11.4.1. COMPANY OVERVIEW
                             11.4.2. REVENUE ANALYSIS
                             11.4.3. PRODUCT PORTFOLIO
                             11.4.4. RECENT DEVELOPEMENTS
                             11.4.5. DATA BRIDGE ANALYSIS
         11.5. KONINKLIJKE PHILIPS N.V..
                             11.5.1. COMPANY OVERVIEW
                            11.5.2. REVENUE ANALYSIS
                            11.5.3. PRODUCT PORTFOLIO
                            11.5.4. RECENT DEVELOPEMENTS
                            11.5.5. DATA BRIDGE ANALYSIS
         11.6. MEDTRONIC, INC. 
                             11.6.1. COMPANY OVERVIEW
                             11.6.2. REVENUE ANALYSIS
                             11.6.3. PRODUCT PORTFOLIO
                              11.6.4. RECENT DEVELOPEMENTS
                              11.6.5. DATA BRIDGE ANALYSIS
         11.7. ST. JUDE MEDICAL
                            11.7.1. COMPANY OVERVIEW
                            11.7.2. REVENUE ANALYSIS
                            11.7.3. PRODUCT PORTFOLIO
                            11.7.4. RECENT DEVELOPEMENTS
                            11.7.5. DATA BRIDGE ANALYSIS
         11.8. SIEMENS AG
                             11.8.1. COMPANY OVERVIEW
                             11.8.2. REVENUE ANALYSIS
                             11.8.3. PRODUCT PORTFOLIO
                             11.8.4. RECENT DEVELOPEMENTS
                             11.8.5. DATA BRIDGE ANALYSIS
         11.9. MICROPORT SCIENTIFIC CORPORATION
                             11.9.1. COMPANY OVERVIEW
                             11.9.2. REVENUE ANALYSIS
                             11.9.3. PRODUCT PORTFOLIO
                             11.9.4. RECENT DEVELOPEMENTS
                             11.9.5. DATA BRIDGE ANALYSIS
         11.10. OSYPKA AG
                             11.10.1. COMPANY OVERVIEW
                             11.10.2. REVENUE ANALYSIS
                             11.10.3. PRODUCT PORTFOLIO
                             11.10.4. RECENT DEVELOPEMENTS
                            11.10.5. DATA BRIDGE ANALYSIS
         11.11. ENDOSENSE SA
                             11.11.1. COMPANY OVERVIEW
                             11.11.2. REVENUE ANALYSIS
                             11.11.3. PRODUCT PORTFOLIO
                             11.11.4. RECENT DEVELOPEMENTS
                             11.11.5. DATA BRIDGE ANALYSIS
         11.12. ATRICURE, INC.
                             11.12.1. COMPANY OVERVIEW
                             11.12.2. REVENUE ANALYSIS
                             11.12.3. PRODUCT PORTFOLIO
                             11.12.4. RECENT DEVELOPEMENTS
                             11.12.5. DATA BRIDGE ANALYSIS
         11.13. CARDIOFOCUS, INC.
                             11.13.1. COMPANY OVERVIEW
                             11.13.2. REVENUE ANALYSIS
                             11.13.3. PRODUCT PORTFOLIO
                             11.13.4. RECENT DEVELOPEMENTS
                             11.13.5. DATA BRIDGE ANALYSIS
         11.14. MOGUL ENTERPRISES, INC.
                            11.14.1. COMPANY OVERVIEW
                            11.14.2. REVENUE ANALYSIS
                            11.14.3. PRODUCT PORTFOLIO
                            11.14.4. RECENT DEVELOPEMENTS
                            11.14.5. DATA BRIDGE ANALYSIS
         11.15. PIONEER MEDICAL DEVICES AG
                            11.15.1. COMPANY OVERVIEW
                            11.15.2. REVENUE ANALYSIS
                            11.15.3. PRODUCT PORTFOLIO
                            11.15.4. RECENT DEVELOPEMENTS
                            11.15.5. DATA BRIDGE ANALYSIS
         11.16. CATHEFFECTS INC
                            11.16.1. COMPANY OVERVIEW
                            11.16.2. REVENUE ANALYSIS
                            11.16.3. PRODUCT PORTFOLIO
                            11.16.4. RECENT DEVELOPEMENTS
                            11.16.5. DATA BRIDGE ANALYSIS
         11.17. JAPAN LIFELINE CO. LTD
                            11.17.1. COMPANY OVERVIEW
                            11.17.2. REVENUE ANALYSIS
                            11.17.3. PRODUCT PORTFOLIO
                           11.17.4. RECENT DEVELOPEMENTS
                           11.17.5. DATA BRIDGE ANALYSIS

12. APPENDIX

13. ABOUT DATA BRIDGE MARKET RESEARCH

List of Table

Please fill in the below form for detailed List of Table

First name is required
Last name is required
Please enter Contact No.
Email is required
Please enter job tital
Please enter company name
Please select country

List of Figure

Please fill in the below form for detailed List of Figure

First name is required
Last name is required
Please enter Contact No.
Email is required
Please enter job tital
Please enter company name
Please select country

View Infographics

Please fill in the below form for detailed Infographics

First name is required
Last name is required
Please enter Contact No.
Email is required
Please enter job tital
Please enter company name
Please select country
CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19